-
Spyre Therapeutics, Inc. (NASDAQ:SYRE) Given Consensus Recommendation of "Buy" by Analysts
Source: Buzz FX / 29 Dec 2024 03:21:13 America/Chicago
Spyre Therapeutics, Inc. (NASDAQ:SYRE) Given Consensus Recommendation of "Buy" by Analysts Written by MarketBeat December 29, 2024 Share Link copied to clipboard. Shares of Spyre Therapeutics, Inc. ( NASDAQ:SYRE - Get Free Report ) have bee
Read more...